Clinical Trials Directory

Trials / Unknown

UnknownNCT01584856

Small Dense Low-density Lipoprotein in Patients With Prediabetes and Type 2 Diabetes

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University of Zurich · Academic / Other
Sex
Male
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

It is known that small dense LDL particles are associated with an increased cardiovascular risk. LDL particles can be separated by gradient gel electrophoresis (GGE) according to their size. The risk to suffer from coronary heart disease is 3-7 fold elevated in subjects with small dense LDL particles compared to subjects with large LDL particles. This study aims at evaluating the predictive value of small dense LDL particles in patients with prediabetes and type 2 diabetes mellitus concerning future changes in intima media thickness, flow-mediated dilation and other risk factors of atherosclerosis (e.g. insulin resistance). 60 patients with prediabetes or type 2 diabetes will be recruited for the study. Assessment will include medical history (risk factors), physical examination (blood pressure, BMI, waist-to-hip ratio), collection of serum, oral glucose tolerance test, measurement of intima media thickness and endothelial dysfunction by ultrasound. All measurements will be repeated after 2 years. Data will be analysed to assess whether the amount of small dense LDL particles can predict further structural and functional changes of the cardiovascular system or changes in the severity of the disease (insulin resistance).

Conditions

Timeline

Start date
2006-05-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2012-04-25
Last updated
2012-04-26

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01584856. Inclusion in this directory is not an endorsement.